22:00 , Mar 22, 2018 |  BC Innovations  |  Strategy

Janssen’s virtual discovery

In the latest example of how AI can accelerate drug discovery, Janssen has shown it can use machine learning to create virtual drug screens that outperform conventional assays. The most promising application may be in...
08:00 , Nov 13, 2014 |  BC Innovations  |  Translation in Brief

Translational tidbits

Kai-Jye Lou and Stephen Parmley, Senior Writers, and Mark Zipkin, Staff Writer  Tankyrase translation   With a few pharmas entering the search for tankyrase inhibitors for cancer, Merck KGaA is hedging its bets by joining...
08:00 , Nov 3, 2014 |  BC Week In Review  |  Company News

J&J pharmaceuticals news

Johnson & Johnson launched its Asia-Pacific Innovation Center, the fourth of J&J's centers. Located in Shanghai with satellite offices in Singapore, Australia and Japan, the center will identify early stage innovations in the areas of...
08:00 , Nov 3, 2014 |  BioCentury  |  Strategy

Translation in Asia

The low concentration of entrepreneurs and venture money in the Asia-Pacific region means Johnson & Johnson 's newest innovation center will initially go about making early stage deals and investments differently than its counterparts in...
04:41 , Oct 29, 2014 |  BC Extra  |  Company News

New deals for J&J's Asia-Pacific Innovation Center

Johnson & Johnson (NYSE:JNJ) launched its Asia Pacific Innovation Center, the fourth of J&J's centers. Located in Shanghai with satellite offices in Singapore, Australia and Japan, the center will identify early stage innovations in the...
07:00 , Jul 24, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Pancreatic cancer G protein-coupled receptor 81 (GPR81) Cell-based, patient sample and mouse studies suggest inhibiting the lactate receptor GPR81 could help treat pancreatic cancer. In...